These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 33165008)

  • 21. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
    Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
    Front Immunol; 2020; 11():596553. PubMed ID: 33324414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.
    Fong SW; Yeo NK; Chan YH; Goh YS; Amrun SN; Ang N; Rajapakse MP; Lum J; Foo S; Lee CY; Carissimo G; Chee RS; Torres-Ruesta A; Tay MZ; Chang ZW; Poh CM; Young BE; Tambyah PA; Kalimuddin S; Leo YS; Lye DC; Lee B; Biswas S; Howland SW; Renia L; Ng LFP
    J Clin Immunol; 2022 Feb; 42(2):214-229. PubMed ID: 34716845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination.
    Koutsakos M; Lee WS; Wheatley AK; Kent SJ; Juno JA
    J Leukoc Biol; 2022 Feb; 111(2):355-365. PubMed ID: 34730247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human CD4
    Verhagen J; van der Meijden ED; Lang V; Kremer AE; Völkl S; Mackensen A; Aigner M; Kremer AN
    Clin Exp Immunol; 2021 Sep; 205(3):363-378. PubMed ID: 34061349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV/SARS-CoV-2 coinfection: A global perspective.
    Kanwugu ON; Adadi P
    J Med Virol; 2021 Feb; 93(2):726-732. PubMed ID: 32692406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-Avidity CD4
    Bacher P; Rosati E; Esser D; Martini GR; Saggau C; Schiminsky E; Dargvainiene J; Schröder I; Wieters I; Khodamoradi Y; Eberhardt F; Vehreschild MJGT; Neb H; Sonntagbauer M; Conrad C; Tran F; Rosenstiel P; Markewitz R; Wandinger KP; Augustin M; Rybniker J; Kochanek M; Leypoldt F; Cornely OA; Koehler P; Franke A; Scheffold A
    Immunity; 2020 Dec; 53(6):1258-1271.e5. PubMed ID: 33296686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV.
    Lv Z; Lv S; Li Q; Xia Y; Feng Z; Zhang H; Yang H; Wu Z; Zou N; Mo Q; Gu Q; Ying S; Wang X; Qin D; Wan C
    Front Immunol; 2023; 14():1264160. PubMed ID: 38045691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
    Policard M; Jain S; Rego S; Dakshanamurthy S
    Virus Res; 2021 Aug; 301():198464. PubMed ID: 34058265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.
    Shi W; Liu X; Cao Q; Ma P; Le W; Xie L; Ye J; Wen W; Tang H; Su W; Zheng Y; Liu Y
    Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L84-L98. PubMed ID: 33146564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.
    Alrubayyi A; Gea-Mallorquí E; Touizer E; Hameiri-Bowen D; Kopycinski J; Charlton B; Fisher-Pearson N; Muir L; Rosa A; Roustan C; Earl C; Cherepanov P; Pellegrino P; Waters L; Burns F; Kinloch S; Dong T; Dorrell L; Rowland-Jones S; McCoy LE; Peppa D
    Nat Commun; 2021 Oct; 12(1):5839. PubMed ID: 34611163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases.
    Sen K; Datta S; Ghosh A; Jha A; Ahad A; Chatterjee S; Suranjika S; Sengupta S; Bhattacharya G; Shriwas O; Avula K; Kshatri J; Prasad P; Swain R; Parida AK; Raghav SK
    Front Immunol; 2021; 12():733539. PubMed ID: 34899693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection.
    Mahalingam SS; Jayaraman S; Arunkumar A; Dudley HM; Anthony DD; Shive CL; Jacobson JM; Pandiyan P
    Front Immunol; 2023; 14():1231087. PubMed ID: 37799713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
    Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP
    Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus.
    Casado-Fernández G; Cantón J; Nasarre L; Ramos-Martín F; Manzanares M; Sánchez-Menéndez C; Fuertes D; Mateos E; Murciano-Antón MA; Pérez-Olmeda M; Cervero M; Torres M; Rodríguez-Rosado R; Coiras M
    Front Immunol; 2024; 15():1362621. PubMed ID: 38812512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.
    Lieber CM; Kang H-J; Sobolik EB; Sticher ZM; Ngo VL; Gewirtz AT; Kolykhalov AA; Natchus MG; Greninger AL; Suthar MS; Plemper RK
    J Virol; 2024 Sep; 98(9):e0090524. PubMed ID: 39207133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
    Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
    Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses.
    Goletti D; Petrone L; Manissero D; Bertoletti A; Rao S; Ndunda N; Sette A; Nikolayevskyy V
    Clin Microbiol Infect; 2021 Dec; 27(12):1784-1789. PubMed ID: 34256141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-reactive CD4
    Loyal L; Braun J; Henze L; Kruse B; Dingeldey M; Reimer U; Kern F; Schwarz T; Mangold M; Unger C; Dörfler F; Kadler S; Rosowski J; Gürcan K; Uyar-Aydin Z; Frentsch M; Kurth F; Schnatbaum K; Eckey M; Hippenstiel S; Hocke A; Müller MA; Sawitzki B; Miltenyi S; Paul F; Mall MA; Wenschuh H; Voigt S; Drosten C; Lauster R; Lachman N; Sander LE; Corman VM; Röhmel J; Meyer-Arndt L; Thiel A; Giesecke-Thiel C
    Science; 2021 Oct; 374(6564):eabh1823. PubMed ID: 34465633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.